• 1
    Helseth A, Mork SJ. Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology. APMIS 1989; 97: 54755.
  • 2
    Stenbeck M, Rosén M. Cancer survival in Sweden in 1961–1991. Acta Oncol 1995; 34: 8393.
  • 3
    Helseth A, Langmark F, Mork SJ. Neoplasms of the central nervous system in Norway. II. Descriptive epidemiology of intracranial neoplasms 1955–1984. APMIS 1988; 96: 106674.
  • 4
    reig NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990; 82: 16214.
  • 5
    Polednak AP. Time trends in incidence of brain and central nervous system cancers in Connecticut. J Natl Cancer Inst 1991; 83: 167981.
  • 6
    Kallio M, Sankila R, Jaaskelainen J, Karjalainen S, Hakulinen T. A population-based study on the incidence and survival rates of 3,857 glioma patients diagnosed from 1953 to 1984. Cancer 1991; 68: 1394400.
  • 7
    Shugg D, Allen BJ, Blizzard L, Dwyer T, Roder D. Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer 1994; 59: 76570.
  • 8
    McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ. The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg 2000; 93: 9329.
  • 9
    Levi F, La Vecchia C. Trends in brain cancer. Lancet 1989; 14;2: 917.
  • 10
    Ahlbom A, Rodvall Y. Brain tumour trends. Lancet 1989; 25;2: 1272.
  • 11
    Davis DL, Hoel D, Percy C, Ahlbom A, Schwartz J. Is brain cancer mortality increasing in industrial countries? Ann NY Acad Sci 1990; 609: 191204.
  • 12
    Davis FG, McCarthy B, Jukich P. The descriptive epidemiology of brain tumors. Neuroimaging Clin N Am 1999; 9: 58194.
  • 13
    Preston-Martin S. Epidemiology of primary CNS neoplasms. Neurol Clin 1996; 14: 27390.
  • 14
    Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev 1995; 17: 382414.
  • 15
    Ron E, Modan B, Boice JDJ, Alfandary E, Stovall M, Chetrit A, Katz L. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319: 10339.
  • 16
    Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 2002; 94: 155563.
  • 17
    Karlsson P, Holmberg E, Lundell M, Mattsson A, Holm LE, Wallgren A. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 1998; 150: 35764.
  • 18
    Hardell L, Nasman A, Pahlson A, Hallquist A, Hansson MK. Use of cellular telephones and the risk for brain tumours: A case-control study. Int J Oncol 1999; 15: 1136.
  • 19
    Dreyer NA, Loughlin JE, Rothman KJ. Cause-specific mortality in cellular telephone users. JAMA 1999; 282: 18146.
  • 20
    Muscat JE, Malkin MG, Thompson S, Shore RE, Stellman SD, McRee D, Meugut AI, Wynder AL. Handheld cellular telephone use and risk of brain cancer. JAMA 2000; 284: 30017.
  • 21
    Johansen C, Boice JD Jr, McLaughlin JK, Olsen JH. Cellular telephones and cancer—a nationwide cohort study in Denmark. Br J Cancer 2001; 93: 2037.
  • 22
    Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS. Cellular-telephone use and brain tumors. N Engl J Med 2001; 344: 7986.
  • 23
    Auvinen A, Hietanen M, Luukkonen R, Koskela RS. Brain tumors and salivary gland cancers among cellular telephone users. Epidemiology 2002; 13: 3569.
  • 24
    Hardell L, Hallquist A, Mild KH, Carlberg M, Påhlson A, Lilja A. Cellular and cordless telephones and the risk for brain tumours. Eur J Cancer Prev 2002; 11: 37786.
  • 25
    American Cancer Society. Manual of tumor nomenclature and coding. New York: American Cancer Society, 1968.
  • 26
    WHO. Statistical code for human tumors. Unpublished documents. WHO/HS/CANC, 24.1 and 24.2. Geneva: WHO, 1956.
  • 27
    Côté RA, Rothwell DJ, Palotay JL, Beckett RS, Brochu L. The systematized nomenclature of medicine: SNOMED International. Northfield, Illinois: College of American Pathologists, 1993.
  • 28
    Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 30513.
  • 29
    Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 3659.
  • 30
    Jensen OM, Storm HH, Jensen HS. Cancer registration in Denmark and the study of multiple primary cancers, 1943–80. Natl Cancer Inst Monogr 1985; 68: 24551.
  • 31
    Lund E. Pilot study for the evaluation of completeness of reporting to the Cancer Registry. Incidence of cancer in Norway 1978. Cancer Registry of Norway, 1981. p 114.
  • 32
    Helseth A. The incidence of primary central nervous system neoplasms before and after computerized tomography availability. J Neurosurg 1995; 83: 9991003.
  • 33
    Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999; 91: 138290.
  • 34
    Greig NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990; 82: 16214.
  • 35
    Kaneko S, Nomura K, Yoshimura T, Yamaguchi N. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973–1993. J Neurooncol 2001; 60: 619.
  • 36
    Velema JP, Walker AM. The age curve of nervous system tumour incidence in adult: common shape but changing levels by sex, race and geographical location. Int J Epidemiol 1987; 6: 17783.
  • 37
    Kleihaus P, Cavenee WK. Tumors of the nervous system. Lyon: IARC, 2000.
  • 38
    Counsell CE, Grant R. Incidence studies of primary and secondary intracranial tumors: A systematic review of their methodology and result. J Neurooncol 1998; 37: 24150.
  • 39
    Desmeules M, Mikkelsen T, Mao Y. Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. J Natl Cancer Inst 1992; 84: 4425.
  • 40
    Dimbylow PJ, Mann SM. SAR calculations in an anatomically realistic model of the head for mobile communication transceivers at 900 MHz and 1.8 GHz. Phys Med Biol 1994; 39: 153753.
  • 41
    Rothman KJ, Chou CK, Morgan R, Balzano Q, Guy AW, Funch DP, Preston-Martin S, Mandel J, Steffens R, Carlo G. Assessment of cellular telephone and other radio frequency exposure for epidemiologic research. Epidemiology 1996; 7: 2918.
  • 42
    Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. International Agency for Research on Cancer, 2001.